Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2016
[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer
Christine E Edmonds, Mehran Makvandi, Brian P Lieberman, et al.
Targeted Oncology
|
February 10, 2018
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Mehran Makvandi, Edouard Dupis, Jonathan W Engle, et al.
Radiology. Imaging Cancer
|
January 28, 2022
The Development of <sup>18</sup>F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1
Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 19, 2022
Imatinib alleviates lung injury and prolongs survival in ventilated rats
Yi Xin, Maurizio Cereda, Nadir Yehya, et al.
ACS Pharmacology & Translational Science
|
February 22, 2021
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
Hannah Dabagian, Tahereh Taghvaee, Paul Martorano, et al.
Bioorganic Chemistry
|
November 4, 2018
Synthesis and evaluation of an AZD2461 [<sup>18</sup>F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant
Sean W Reilly, Laura N Puentes, Alexander Schmitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
Vandana Batra, Minu Samanta, Mehran Makvandi, et al.
Nuclear Medicine and Biology
|
October 3, 2019
Improved production of <sup>76</sup>Br, <sup>77</sup>Br and <sup>80m</sup>Br via CoSe cyclotron targets and vertical dry distillation
Paul A Ellison, Aeli P Olson, Todd E Barnhart, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
American Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2016
[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer
Christine E Edmonds, Mehran Makvandi, Brian P Lieberman, et al.
Targeted Oncology
|
February 10, 2018
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Mehran Makvandi, Edouard Dupis, Jonathan W Engle, et al.
Radiology. Imaging Cancer
|
January 28, 2022
The Development of <sup>18</sup>F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1
Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 19, 2022
Imatinib alleviates lung injury and prolongs survival in ventilated rats
Yi Xin, Maurizio Cereda, Nadir Yehya, et al.
ACS Pharmacology & Translational Science
|
February 22, 2021
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
Hannah Dabagian, Tahereh Taghvaee, Paul Martorano, et al.
Bioorganic Chemistry
|
November 4, 2018
Synthesis and evaluation of an AZD2461 [<sup>18</sup>F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant
Sean W Reilly, Laura N Puentes, Alexander Schmitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
Vandana Batra, Minu Samanta, Mehran Makvandi, et al.
Nuclear Medicine and Biology
|
October 3, 2019
Improved production of <sup>76</sup>Br, <sup>77</sup>Br and <sup>80m</sup>Br via CoSe cyclotron targets and vertical dry distillation
Paul A Ellison, Aeli P Olson, Todd E Barnhart, et al.
Page
of 4